ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148,285 | -25.1% | 56,814 | +2.7% | 0.00% | – |
| Q2 2023 | $197,981 | +68.6% | 55,302 | +2.7% | 0.00% | – |
| Q1 2023 | $117,428 | -90.4% | 53,866 | -47.2% | 0.00% | – |
| Q4 2022 | $1,226,892 | +302.3% | 101,986 | +117.0% | 0.00% | – |
| Q3 2022 | $305,000 | +44.5% | 46,992 | +2.1% | 0.00% | – |
| Q2 2022 | $211,000 | -95.5% | 46,009 | -91.4% | 0.00% | – |
| Q1 2022 | $4,651,000 | -36.4% | 537,670 | +5.0% | 0.00% | – |
| Q4 2021 | $7,315,000 | -31.8% | 512,246 | +5.0% | 0.00% | -100.0% |
| Q3 2021 | $10,726,000 | +127.8% | 487,999 | +38.7% | 0.00% | – |
| Q2 2021 | $4,709,000 | – | 351,920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
| Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
| FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
| Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
| Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |